Close loopholes for blocking generics, activists’ report says
PATIENTS are being denied life-saving medicines because SA’s patent regime allows multinational drug companies readily to block cheaper generic rivals and stifle competition, according to a report from health activists lobbying the government for legal reform.The Fix the Patent Laws Campaign says SA’s legal framework for patents makes it too easy for pharmaceutical companies to extend their monopoly period on drugs, sometimes for years after it has expired elsewhere in the world.The coalition has 32 organisations including Doctors without Borders (MSF), the Treatment Action Campaign and patient advocacy groups for epilepsy, cancer and mental health."Companies commonly apply for multiple patents on individual medicines over time — a tactic known as ever-greening."Due to shortcomings in SA’s laws — namely the lack of examination for patent applications — ever-greening occurs frequently," according to the report.It says patients — both rich and poor — are denied vital medicines because...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.